Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain SUPN message board posts where the ticker symbol SUPN has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest SUPN SEC Filings

Filings Format Description Filing Date File/Film Number
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001104659-18-050920 (34 Act)  Size: 6 MB
2018-08-09 001-35518
181004722
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001104659-18-050207 (34 Act)  Size: 266 KB
2018-08-07 001-35518
18999228
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001104659-18-047769 (34 Act)  Size: 44 KB
2018-07-27 001-35518
18975611
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001104659-18-043825 Size: 12 KB
2018-07-03
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001104659-18-043597 Size: 5 KB
2018-07-02
3  Documents Initial statement of beneficial ownership of securities
Acc-no: 0001104659-18-043595 Size: 10 KB
2018-07-02
8-K  Documents Current report, items 5.02, 8.01, and 9.01
Acc-no: 0001104659-18-043589 (34 Act)  Size: 54 KB
2018-07-02 001-35518
18933969
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001104659-18-043279 Size: 11 KB
2018-06-29
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001104659-18-041853 Size: 9 KB
2018-06-22
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001104659-18-041086 Size: 12 KB
2018-06-19
More SUPN SEC Filings


Related news from
Wed, 08 Aug 2018
20:18:14 +0000
IBD 50's Supernus Pharma Topples As Key Epilepsy Drug Sales Lag
Supernus Pharmaceuticals on Wednesday reported income of 57 cents per share on sales of $99.5 million for its second quarter.
Wed, 08 Aug 2018
19:01:00 +0000
Why Supernus Pharmaceuticals, Inc. Is Falling Today
Shares sell off after the company posts mixed second-quarter results. Here's what investors need to know.
Wed, 08 Aug 2018
19:00:06 +0000
Google Owner Defies Stock Market Blues As This Internet Stock Goes En Fuego
Major equity indexes took a break on Wednesday, but the stock market bulls continued to pile into top-rated internet content stocks.
Wed, 08 Aug 2018
11:00:00 +0000
Supernus Pharmaceuticals, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / August 8, 2018 / Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 8, 2018 at 9:00 AM Eastern ...
Tue, 07 Aug 2018
23:05:11 +0000
Supernus Pharmaceuticals (SUPN) Surpasses Q2 Earnings Estimates
Supernus (SUPN) delivered earnings and revenue surprises of 29.55% and -1.46%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Tue, 07 Aug 2018
21:59:49 +0000
Supernus: 2Q Earnings Snapshot
On a per-share basis, the Rockville, Maryland-based company said it had net income of 57 cents. The results exceeded Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment ...
Tue, 07 Aug 2018
20:15:00 +0000
Supernus Announces Second Quarter 2018 Financial Results and Record Quarterly Revenue
Total revenue of $99.5 million, a 31% increase over 2017 Net product sales of $97.0 million, a 32% increase over 2017 Operating earnings of $35.7 million, a 37% increase over 2017 Diluted earnings per ...
Thu, 02 Aug 2018
12:05:41 +0000
See what the IHS Markit Score report has to say about Supernus Pharmaceuticals Inc.
Short interest is moderately high for SUPN with between 10 and 15% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. The net inflows of $1.38 billion over the last one-month into ETFs that hold SUPN are among the lowest of the last year and appear to be slowing.
Wed, 25 Jul 2018
20:15:00 +0000
Supernus to Host Second Quarter 2018 Earnings Conference Call
ROCKVILLE, Md., July 25, 2018-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ...
Fri, 20 Jul 2018
10:00:00 +0000
5 Favorite Biotech Bets
Given their dependence on the success or failure of their drug candidates, biotechnology stocks are generally high-risk propositions. Over the past couple of decades our most profitable sector has been biotech stocks. Of course, the key to almost any stock move is news.
Thu, 19 Jul 2018
11:50:00 +0000
Initiating Free Research Reports on Horizon Pharma and Three Other Healthcare Equities
LONDON, UK / ACCESSWIRE / July 19, 2018 / If you want a free Stock Review on HZNP sign up now at www.wallstequities.com/registration. All you have to do is sign up today for this free limited time offer by clicking the link below.
Wed, 27 Jun 2018
20:30:00 +0000
Dr. Carrolee Barlow, M.D., Ph.D., Joins Supernus’ Board of Directors
Supernus Pharmaceuticals, Inc. (SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that Dr. Carrolee Barlow, M.D., Ph.D., has joined Supernus’ Board of Directors effective immediately. Dr. Barlow is an expert in neuroscience and neurodegeneration, and is currently the Chief Executive Officer of the Parkinson’s Institute and Clinical Center, Sunnyvale, California. “Dr. Barlow’s deep expertise in neurology, as well as her strategic, operational and academic experience, will add significant value to our Board and to the Company,” said Jack Khattar, President and CEO of Supernus Pharmaceuticals.
Sun, 24 Jun 2018
14:38:16 +0000
These Factors Make Supernus Pharmaceuticals Inc (NASDAQ:SUPN) A Great Investment
Supernus Pharmaceuticals Inc (NASDAQ:SUPN) is a company with exceptional fundamental characteristics. Upon building up an investment case for a stock, we should look at various aspects. In the case ofRead More...
Wed, 20 Jun 2018
19:01:15 +0000
Brief Commentary On Supernus Pharmaceuticals Inc’s (NASDAQ:SUPN) Fundamentals
Attractive stocks have exceptional fundamentals. In the case of Supernus Pharmaceuticals Inc (NASDAQ:SUPN), there’s is a financially-robust company with a strong track record and a buoyant growth outlook. Below isRead More...
Mon, 18 Jun 2018
11:05:00 +0000
Free Research Reports on Ironwood Pharma and Three More Generic Drugs Stocks
LONDON, UK / ACCESSWIRE / June 18, 2018/ If you want a free Stock Review on IRWD sign up now at www.wallstequities.com/registration. In today's pre-market research, WallStEquities.com observes the recent performance of Horizon Pharma PLC (NASDAQ: HZNP), Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD), Lipocine Inc. (NASDAQ: LPCN), and Supernus Pharmaceuticals Inc. (NASDAQ: SUPN).
Tue, 05 Jun 2018
11:55:00 +0000
Recent Analysis Shows Supernus Pharmaceuticals, R1 RCM, Golar LNG, Chemical Financial, Chipmos Technologies, and Tower Semiconductor Market Influences — Renewed Outlook, Key Drivers of Growth
NEW YORK, June 05, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Supernus ...
Fri, 01 Jun 2018
13:00:00 +0000
Faruqi & Faruqi, LLP is Investigating Supernus Pharmaceuticals, Inc. (SUPN) on Behalf of its Shareholders
NEW YORK , June 1, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities law violations at Supernus Pharmaceuticals, Inc. ("Supernus" ...



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "This is the most knowledgable group I've ever been associated with (23 years). It is also the most unselfish and there is never any name calling or putting members down. ValueForum has helped me be very successful." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards